IP Library › Assignment 025003/0201
Patent Assignment
Reel/Frame 025003/0201

Merger

Recorded: 2010-09-17 Pages: 80
Assignor
TAP PHARMACEUTICAL PRODUCTS, INC.
Executed: 2008-06-30
Assignee
TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
ONE TAKEDA PARKWAY, DEERFIELD, ILLINOIS, 60015
Covered Properties (2)
Methods for Treating Nephrolithiasis
Patent: 8,841,333 →
Application: 11/429,734 →
Publication: US 2006/0252808
Methods for Preserving Renal Function Using Xanthine Oxidoreductase Inhibitors
Application: 11/939,112 →
Publication: US 2008/0269226
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 27, 2006
From: JOSEPH-RIDGE, NANCY
To: TAP PHARMACEUTICAL PRODUCTS, INC.
Reel/Frame 017856/0895 →
Assignment of Assignor's Interest Jul 8, 2008
From: LADEMACHER, CHRISTOPHER; MACDONALD, PATRICIA
To: TAP PHARMACEUTICAL PRODUCTS, INC.
Reel/Frame 021206/0531 →
Change of Name Apr 2, 2012
From: TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.,
To: TAKEDA PHARMACEUTICALS U.S.A., INC.
Reel/Frame 027971/0541 →